Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for prevention of bronchopulmonary dysplasia in preterm neonates
IRCT20230526058294N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in bronchopulmonary dysplasia (BPD) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Bronchopulmonary dysplasia. Started Apr 2023; status: completed.
02
Drugs
melatonin
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on IRCT20230526058294N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230526058294N1.